LONDON (Reuters) - Elderly patients with an aggressive form of blood cancer lived about 20 months longer when given the drug thalidomide as part of their treatment, French researchers said on Friday.The drug also slowed the spread of myeloma, a disease that accounts for about 1-2 percent of all cancers, usually affects older people, and kills its victims within three years, they reported in the Lancet medical journal.
